PHS
CMTA

PFM Health Sciences’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

PFM Health Sciences’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-849,904
Closed -$9.99M – 125
2018
Q4 		$9.99M Buy
849,904
+527,172
+163% +$6.56M 0.27% 71
2018
Q3 		$3.6M Hold
322,732
– – 0.05% 113
2018
Q2 		$4.25M Hold
322,732
– – 0.07% 109
2018
Q1 		$4.89M Buy
322,732
+10,977
+4% +$179K 0.1% 88
2017
Q4 		$5.92M Sell
311,755
-25,446
-8% -$426K 0.14% 78
2017
Q3 		$5.7M Buy
+337,201
New +$5.51M 0.11% 85

Other funds holding CMTA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KLCMU
Kite Lake Capital Management (UK) London, United Kingdom $125M AUM 198.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

PFM Health Sciences's CMTA Position: Q1 2019 in Review

PFM Health Sciences sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q1 2019, closing a stake of 849,904 shares — an estimated $9.99M sold.

PFM Health Sciences first reported a position in CMTA in Q3 2017 and held it in 6 quarters. The position peaked at $9.99M in Q4 2018. 48 funds tracked by Wall St. Rank hold CMTA as of Q1 2019.

  • PFM Health Sciences reported no remaining Clementia Pharmaceuticals Inc. position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 849,904 Clementia Pharmaceuticals Inc. shares in Q1 2019, an estimated $9.99M.
  • PFM Health Sciences first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 6 quarters.
  • PFM Health Sciences's Clementia Pharmaceuticals Inc. position peaked at $9.99M in Q4 2018.
  • 48 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.